Altshuler Shaham’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-25,123
| Closed | -$30.1K | – | 378 |
|
|
2023
Q4 | $30.1K | Hold |
25,123
| – | – | ﹤0.01% | 145 |
|
|
2023
Q3 | $121K | Hold |
25,123
| – | – | ﹤0.01% | 100 |
|
|
2023
Q2 | $97.7K | Hold |
25,123
| – | – | ﹤0.01% | 127 |
|
|
2023
Q1 | $63.1K | Hold |
25,123
| – | – | ﹤0.01% | 175 |
|
|
2022
Q4 | $45.7K | Sell |
25,123
-1
| -0% | -$5 | ﹤0.01% | 243 |
|
|
2022
Q3 | $153K | Sell |
25,124
-1,818
| -7% | -$21.9K | ﹤0.01% | 134 |
|
|
2022
Q2 | $291K | Sell |
26,942
-279
| -1% | -$3.85K | ﹤0.01% | 116 |
|
|
2022
Q1 | $609K | Sell |
27,221
-1,718
| -6% | -$33.8K | 0.01% | 178 |
|
|
2021
Q4 | $828K | Hold |
28,939
| – | – | 0.01% | 178 |
|
|
2021
Q3 | $1.9M | Hold |
28,939
| – | – | 0.01% | 137 |
|
|
2021
Q2 | $2.3M | Hold |
28,939
| – | – | 0.02% | 139 |
|
|
2021
Q1 | $3.84M | Hold |
28,939
| – | – | 0.04% | 53 |
|
|
2020
Q4 | $4.61M | Hold |
28,939
| – | – | 0.09% | 35 |
|
|
2020
Q3 | $3.04M | Hold |
28,939
| – | – | 0.07% | 44 |
|
|
2020
Q2 | $3.51M | Buy |
28,939
+411
| +1% | +$46.5K | 0.11% | 30 |
|
|
2020
Q1 | $2.24M | Buy |
28,528
+1,153
| +4% | +$188K | 0.1% | 34 |
|
|
2019
Q4 | $8.06M | Hold |
27,375
| – | – | 0.23% | 24 |
|
|
2019
Q3 | $4.9M | Buy |
27,375
+29
| +0.1% | +$8.25K | 0.19% | 21 |
|
|
2019
Q2 | $11.3M | Buy |
27,346
+6,074
| +29% | +$2.56M | 0.48% | 19 |
|
|
2019
Q1 | $9.94M | Buy |
21,272
+230
| +1% | +$112K | 0.45% | 19 |
|
|
2018
Q4 | $10.1M | Sell |
21,042
-9
| -0% | -$4.97K | 0.44% | 27 |
|
|
2018
Q3 | $14.3M | Buy |
+21,051
| New | +$13.5M | 0.76% | 20 |
|
Other funds holding ELOX
Altshuler Shaham's ELOX Position: Q1 2024 in Review
Altshuler Shaham sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q1 2024, closing a stake of 25,123 shares — an estimated $30.1K sold.
Altshuler Shaham first reported a position in ELOX in Q3 2018 and held it in 22 quarters. The position peaked at $14.3M in Q3 2018. 1 fund tracked by Wall St. Rank holds ELOX as of Q1 2024.
- Altshuler Shaham reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- Altshuler Shaham sold 25,123 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $30.1K.
- Altshuler Shaham first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 22 quarters.
- Altshuler Shaham's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $14.3M in Q3 2018.
- 1 fund tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q1 2024.
Based on Altshuler Shaham's 13F filing for Q1 2024, filed 15 May 2024.